Departamento de Medicina Interna, Hospital Universitario San Ignacio - Bogotá, Colômbia.
Facultad de Medicina, Pontificia Universidad Javeriana - Bogotá, Colômbia.
Rev Bras Ter Intensiva. 2020 Oct-Dec;32(4):578-584. doi: 10.5935/0103-507X.20200096.
To determine the concordance of mortality risk classification through the use of the Pediatric Index of Mortality (PIM) 2 and 3.
Through a retrospective cohort, we evaluated patients admitted to the pediatric intensive care unit between April 2016 and December 2018. We calculated the mortality risk with the PIM 2 and 3. Analyses were carried out to determine the concordance between the risk classification obtained with both scales using unweighted and linearly weighted kappa.
A total of 722 subjects were included, and 66.6% had a chronic condition. The overall mortality was 3.7%. The global kappa concordance coefficient for classifying patients according to risk with the PIM 2 and 3 was moderate at 0.48 (95%CI 0.43 - 0.53). After linear weighting, concordance was substantial at 0.64 (95%CI 0.59 - 0.69). For cardiac surgery patients, concordance for risk classification was fair at 0.30 (95%CI 0.21 - 0.39), and after linear weighting, concordance was only moderate at 0.49 (95%CI 0.39 - 0.59). The PIM 3 assigned a lower risk than the PIM 2 in 44.8% of patients in this subgroup.
Our study proves that the PIM 2 and 3 are not clinically equivalent and should not be used interchangeably for quality evaluation across pediatric intensive care units. Validation studies must be performed before using the PIM 2 or PIM 3 in specific settings.
通过使用儿科死亡率指数(PIM)2 和 3 来确定死亡率风险分类的一致性。
通过回顾性队列研究,我们评估了 2016 年 4 月至 2018 年 12 月期间入住儿科重症监护病房的患者。我们使用 PIM 2 和 3 计算死亡率风险。通过未加权和线性加权 kappa 分析,对两种量表获得的风险分类进行一致性分析。
共纳入 722 例患者,66.6%有慢性疾病。总体死亡率为 3.7%。根据 PIM 2 和 3 对患者进行风险分类的全球 kappa 一致性系数为中度,为 0.48(95%CI 0.43-0.53)。线性加权后,一致性为 0.64(95%CI 0.59-0.69)。对于心脏手术患者,风险分类的一致性为 0.30(95%CI 0.21-0.39),线性加权后仅为 0.49(95%CI 0.39-0.59)。在这个亚组中,44.8%的患者的 PIM 3 风险评估低于 PIM 2。
我们的研究证明 PIM 2 和 3 在临床上并不等效,不应在儿科重症监护病房之间的质量评估中互换使用。在特定环境中使用 PIM 2 或 PIM 3 之前,必须进行验证研究。